LH News and Press, Laboratory Corporation of America Holdings From 07/13/23

Labcorp Finalizes Strategic Relationship with Jefferson Health PR Newswire BURLINGTON, N.C. , July 13, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, today announced the completion of the previo...

LABCORP AND LEGACY HEALTH AGREE TO COMPREHENSIVE LABORATORY RELATIONSHIP PR Newswire Agreement Will Expand Access to Labcorp's Diagnostics Capabilities and Improve Services BURLINGTON, N.C. , July 11, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global lead...

2023-07-05 19:23:09 ET Summary Laboratory Corporation of America Holdings shares have been hurt by the boom-bust cycle induced by the pandemic. Tough comparables should run off in the coming quarters, as the company is simplifying the business with the Fortrea spinoff. Overall...

2023-07-05 13:50:38 ET Newly public Fortrea ( NASDAQ: FTRE ), a spin out of Labcorp, saw its shares dip 4% in afternoon trading Wednesday during its second day as a separately traded company. Labcorp ( NYSE: LH ) spun out Fortrea as an independent contract research organ...

2023-07-05 12:07:51 ET Summary Fortrea was spun off from Labcorp on July 3. I am rating the new company as a strong hold based upon its long history of financial success, its strong position in a growing industry, its extensive capabilities, and valuation. I am waiting for for...

2023-07-03 12:59:12 ET Shares of Laboratory Corp. of America (NYSE: LH) , also known as Labcorp, were down more than 13% as of 12:15 p.m. ET on Monday after the company announced it had completed its spinoff of Fortrea Holdings (NASDAQ: FTRE), a contract research organization. T...

2023-07-03 10:30:53 ET Gainers: Ensysce Biosciences ( ENSC ) +20% . Journey Medical ( DERM ) +20% . Ventyx Biosciences ( VTYX ) +16% . PainReform ( PRFX ) +12% . iCAD ( ICAD ) +7% . Losers: Protagonist Therapeutics ( PTG...

Company completes spin-off from Labcorp and begins trading on Nasdaq under ticker “FTRE” Independent company positioned to capitalize on growth opportunities in phases I-IV clinical trials and patient access, and to extend leading positions in oncology, clinical pharmacolo...

Labcorp Completes Spin-off of Fortrea PR Newswire BURLINGTON, N.C. , July 3, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that it has completed the spin-off of Fortrea, the newly...

2023-07-02 12:00:52 ET The tables have turned for Contract services organizations (CROs), with their toplines under pressure amid a post-pandemic drop in demand for clinical trial services worsened by biotech’s funding woes. The group offers clinical trial management services for...